Literature DB >> 599353

Acetylcholinesterase activity and menstrual remissions in myasthenia gravis.

N Vijayan, V K Vijayan, P M Dreyfus.   

Abstract

Menstrually related temporary remissions of myasthenic symptoms are reported to occur in 25 to 50% of female patients. Even though this has been attributed to hormonal changes associated with the menstrual cycle the underlying mechanism of this hormonal influence has remained elusive. The present study demonstrated a cyclical variation in the activity of red cell acetylcholinesterase (EC 3.1.1.7) enzyme (AChE) with a marked reduction at the time of menstrual remission of symptoms of myasthenia. These cyclical changes were abolished by thymectomy. It appears, therefore, that menstrual remission in myasthenia is at least partly due to hormone-induced changes in AChE activity. This process seems to be under the control of the thymus gland.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 599353      PMCID: PMC492903          DOI: 10.1136/jnnp.40.11.1060

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Hormone action and membrane fluidity: effect of insulin and cortisol on the Hill coefficients of rat erythrocyte membrane-bound acetylcholinesterase and (Na+ + K+)-ATPase.

Authors:  E M Massa; R D Morero; B Bloj; R N Farías
Journal:  Biochem Biophys Res Commun       Date:  1975-09-02       Impact factor: 3.575

2.  Sex differences in brain pseudo-cholinesterase activity in the rat.

Authors:  D E WOOLLEY
Journal:  J Neurochem       Date:  1963-06       Impact factor: 5.372

3.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

4.  Progesterone metabolism in myasthenia gravis.

Authors:  I SCHRIRE
Journal:  Q J Med       Date:  1959-01

5.  Progesterone block.

Authors:  A CSAPO
Journal:  Am J Anat       Date:  1956-03

6.  Obstetrics and gynaecology in relation to thyrotoxicosis and myasthenia gravis.

Authors:  G KEYNES
Journal:  J Obstet Gynaecol Br Emp       Date:  1952-04

7.  Studies in the cholinesterase-hormone relationship.

Authors:  A C BARNES; J W EPPERSON
Journal:  Am J Obstet Gynecol       Date:  1952-02       Impact factor: 8.661

Review 8.  Estrogen action: an inroad to cell biology.

Authors:  G C Mueller; B Vonderhaar; U H Kim; M Le Mahieu
Journal:  Recent Prog Horm Res       Date:  1972

9.  Effect of age of the rat on induction of acetylcholinesterase of the brain by 17 beta-estradiol.

Authors:  V K Moudgil; M S Kanungo
Journal:  Biochim Biophys Acta       Date:  1973-12-05

10.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

View more
  3 in total

1.  Differential estrogen receptor expression in autoimmune myasthenia gravis.

Authors:  Patrice Nancy; Sonia Berrih-Aknin
Journal:  Endocrinology       Date:  2005-01-20       Impact factor: 4.736

Review 2.  Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica.

Authors:  Zhen Wang; Yaping Yan
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

3.  Prioritizing genes of potential relevance to diseases affected by sex hormones: an example of myasthenia gravis.

Authors:  Mandeep Kaur; Sebastian Schmeier; Cameron R MacPherson; Oliver Hofmann; Winston A Hide; Stephen Taylor; Nick Willcox; Vladimir B Bajic
Journal:  BMC Genomics       Date:  2008-10-13       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.